Endogenous tripeptide (Gly-His-Lys); the copper-bound form (GHK-Cu) is the well-studied ligand.
Tripeptide that acts as a copper carrier in the body. Pure GHK is often studied separately from GHK-Cu but has overlapping wound-healing and extracellular-matrix modulation activity.
Evidence summary in progress. See the citations section below for the underlying research papers.
No FDA label or editorial side-effect profile is on file for this compound yet. See the clinical trials and citations sections for study-reported safety data.
No documented drug interactions on file.
Not FDA approved. Used in cosmetic formulations and available through compounding pharmacies.
Available through compounding pharmacies with valid prescription.
Regulatory data last verified 4/19/2026
Showing 20 of 30 papers. View all on PubMed →